Drug Development, Mental health, Public Health and Survey

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Drug Development

Mental health

Public Health

Survey

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Digital Health Global

JANUARY 26, 2024

NEW YORK–(BUSINESS WIRE)– Deliberate AI , a digital health technology company that delivers precision measurement of mental health through AI, today announced its inclusion in the U.S. Food and Drug Administration (FDA) Innovative Science and Technology Approaches for New Drugs (ISTAND) Pilot Program.

Drug Development

Drug Development Mental health Psychiatry Digital Health

Uses of AI in Healthcare – 2024 Health IT Predictions

Healthcare IT Today

JANUARY 17, 2024

Dr. Carl Marci, Chief Psychiatrist and Managing Director of Mental Health at OM1 The industry needs commitment, not hype related to AI in mental health: As we move into the new year, the industry will continue the hype-cycle around the myriad uses of AI in mental health. Carolyn Ward, M.D. Enter academia.

Health IT

Health IT Mental health Interoperability Patient Experience

Connected Health Pulse

Deliberate AI Announces its Depression and Anxiety Model, AI-COA™, is the First AI/ML Initiative to Be Accepted into the FDA’s ISTAND Pilot Program to Advance Drug Development

Uses of AI in Healthcare – 2024 Health IT Predictions

Stay Connected